Fermenta Biotech Limited Stock

Equities

FERMENTA

INE225B01021

Pharmaceuticals

Market Closed - Bombay S.E. 06:23:19 2024-04-24 am EDT 5-day change 1st Jan Change
183 INR +3.24% Intraday chart for Fermenta Biotech Limited +5.66% +13.24%
Sales 2022 3.99B 47.87M Sales 2023 3.5B 42.03M Capitalization 3.09B 37.06M
Net income 2022 154M 1.85M Net income 2023 -515M -6.19M EV / Sales 2022 2.02 x
Net Debt 2022 2.13B 25.63M Net Debt 2023 1.6B 19.18M EV / Sales 2023 1.34 x
P/E ratio 2022
38.6 x
P/E ratio 2023
-5.99 x
Employees 550
Yield 2022
0.61%
Yield 2023
1.17%
Free-Float 25.21%
More Fundamentals * Assessed data
Dynamic Chart
Fermenta Biotech Sells Premises in Thane, India for INR136 Million MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Fermenta Biotech Sells Land in Pune, India for INR448 Million MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB; Outlook Negative MT
Fermenta Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Fermenta Biotech Opens Premix Plant in Kullu, India MT
Fermenta Biotech Limited Announces Inauguration of Customized Premix Manufacturing Plant in Kullu, Himachal Pradesh CI
Fermenta Biotech Resumes Full Operations of Kullu Plant in Himachal Pradesh, India MT
Fermenta Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Fermenta Biotech Resumes Partial Operations at Himachal Pradesh, India Facility MT
Fermenta Biotech Halts Operations at Himachal Pradesh, India Facility Due to Heavy Rain MT
Fermenta Biotech Limited Announces Suspension of Operations Due to Heavy Rainfall in Himachal Pradesh CI
Fermenta Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Fermenta Biotech Sells Premises in Thane, India for INR66 Million MT
More news
1 day+0.82%
1 week+3.18%
Current month+18.03%
1 month+19.73%
3 months+15.22%
6 months+2.00%
Current year+10.58%
More quotes
1 week
166.50
Extreme 166.5
183.45
1 month
146.00
Extreme 146
183.45
Current year
146.00
Extreme 146
214.00
1 year
132.30
Extreme 132.3
214.00
3 years
103.30
Extreme 103.3
370.00
5 years
103.30
Extreme 103.3
442.00
10 years
39.19
Extreme 39.1917
442.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 21-05-05
Director of Finance/CFO - 17-02-15
Compliance Officer - Feb. 11
Members of the board TitleAgeSince
Director/Board Member 83 19-05-16
Director/Board Member 54 22-08-11
Director/Board Member 42 01-09-02
More insiders
Date Price Change Volume
24-04-24 183 +3.24% 28 613
24-04-23 177.2 +2.84% 22,554
24-04-22 172.4 +1.59% 11,107
24-04-19 169.6 -2.05% 8,487
24-04-18 173.2 +1.38% 11,517

Delayed Quote Bombay S.E., April 24, 2024 at 03:23 am EDT

More quotes
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. The Company's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The Company has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The Company provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FERMENTA Stock